Explicit|||133..145||nevertheless||1|nevertheless|||Comparison.Concession|||||||||||0..131|0|with no breakthrough hpv infections due to waning immunity, the minimum protective anti hpv antibody level could not be ascertained||||||||146..311|1|antibody titer has been used as a surrogate marker of protection in clinical trials, particularly in adolescent populations in whom efficacy studies are not feasible|||||||||||||
